Clinical trial
A Study of ZN-c5 and Abemaciclib in Participants With Breast Cancer
NCT04514159
Study timeline
Study start (actual)2020-11-12Date precision: day
Registry last updated2023-02-01
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Cancerunresolved
Interventions
ZN-c5DRUG
AbemaciclibDRUG · verified · RxNorm: abemaciclib
Sponsors & collaborators
Zeno Alpha Inc.lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04514159 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.